Upgrade to SI Premium - Free Trial

Cerebras jumps 4% as analysts launch bullish coverage

June 8, 2026 7:18 AM

Investing.com -- Shares of Cerebras Systems (NASDAQ: CBRS) jumped 4% on Monday, driven by a massive wave of bullish sentiment from Wall Street. As the company’s post-IPO quiet period officially expired, nine major brokerages initiated coverage on the AI chipmaker—all issuing the equivalent of a "Buy" rating.

Analysts across the board are hailing Cerebras as the most formidable and uniquely positioned challenger to NVIDIA’s market dominance, pointing to its radical "wafer-scale" architecture and massive multi-billion-dollar backlogs as key growth drivers.

The central theme across the newly released research notes is Cerebras’ absolute advantage in fast inference—the process of running live AI models, which is rapidly shifting toward reasoning-intensive tasks and real-time AI agents.

While traditional chipmakers link together thousands of smaller GPUs, Cerebras manufactures the Wafer-Scale Engine (WSE), the world’s largest single compute chip. By keeping massive amounts of SRAM (memory) directly on a single piece of silicon, Cerebras eliminates the latency bottlenecks that plague traditional hardware configurations.

"Cerebras reaches the public market just as the compute cycle pivots from training to inference; the part of the market where speed, not raw FLOPs, dictates output value," noted Wedbush analyst Matt Bryson. He called the setup "asymmetric and upside-skewed."

Barclays analyst Tom O’Malley echoed this enthusiasm, noting that the fast-inference Total Addressable Market (TAM) could reach $300 billion by the end of the decade. Mizuho was even more aggressive, projecting the fast-inference segment alone to grow at a staggering 291% CAGR to reach ~$550 billion by 2030.

Wall Street’s hyper-growth projections are backed by massive, locked-in commercial contracts. Analysts highlighted two massive validation points that differentiate Cerebras from speculative AI startups:


  1. The $20B+ OpenAI Blockbuster: In January 2026, Cerebras signed a monumental multi-year deal with OpenAI. The ChatGPT creator is deploying ~750MW of Cerebras compute capacity through 2028, with an option to add another 1.25GW. Notably, UBS highlighted that Cerebras is currently the only supplier shipping to OpenAI under a pre-payment structure.


  2. The AWS Collaboration: In March 2026, Cerebras announced a major partnership with Amazon Web Services (AWS) for disaggregated inference, providing an alternative cloud pipeline for enterprises seeking ultra-low-latency AI workloads.



According to Rosenblatt Securities, these partnerships are triggering a massive revenue inflection. The firm noted that Cerebras scaled its annual revenue from just $25 million in 2022 to an impressive $510 million in 2025, with projections hitting $6.8 billion by 2028.

Every single one of the nine analysts initiating coverage on Monday came out with a highly favorable outlook. Price targets range from $250.00 to $340.00, representing massive upside from current trading levels.

Investment BankAnalystRatingPrice Target
CitiAtif MalikBuy$340.00
UBSTimothy ArcuriBuy$300.00
MizuhoVijay RakeshOutperform$300.00
NeedhamN. Quinn BoltonBuy$300.00
RosenblattKevin CassidyBuy$300.00
BarclaysTom O’MalleyOverweight$280.00
TD CowenJoshua Buchalter Buy$275.00
WedbushMatt BrysonOutperform$270.00
Morgan StanleyJoseph MooreOverweight$250.00

The Bottom Line

With a proprietary hardware stack that creates a deep moat, an explosive 122% projected revenue CAGR through 2029, and foundational backing from the biggest names in AI, Wall Street sees Cerebras as a structural winner. As Morgan Stanley’s Joseph Moore summarized, CBRS offers investors a "unique chance to invest in an AI processor company with a first-mover advantage against NVIDIA."

Categories

General News Investing